CapsoVision (CV) EBT (2024 - 2025)
CapsoVision's (CV) quarterly EBT came in at -$7.4 million in Q4 2025, down 59.25% year-on-year from -$18.1 million in Q4 2024, and up 6.96% quarter-over-quarter from -$7.9 million in Q3 2025.
CapsoVision (CV) EBT (2024 - 2025) Analysis & Trends
CapsoVision has disclosed EBT across 2 years of filings, most recently posting -$7.4 million for Q4 2025.
- EBT for Q4 2025 came in at -$7.4 million, down 59.25% year-over-year; the trailing twelve-month figure through Dec 2025 was -$24.5 million (changed N/A YoY), and the FY2025 annual result was -$25.3 million, down 27.17% from the prior year.
- EBT came in at -$7.4 million for Q4 2025 at CapsoVision, up from -$7.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$4.6 million in Q2 2025 to a low of -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.40 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 222.44 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 269.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 304.50 Mn |
| 10 | CapsoVision | 161.82 Mn | 151.71 Mn | 1.95 Mn | -7.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.37 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -5.27 Mn |